Skip to search formSkip to main contentSkip to account menu

gacyclidine

Known as: Piperidine, 1-(2-methyl-1-(2-thienyl)cyclohexyl)-, cis-, methyl-2-r-(piperidine-1-)-1-(thienyl-2)1-cyclohexene 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
TCP and its derivative gacyclidine (± GK11) are high‐affinity non‐competitive antagonists of N‐methyl‐D‐aspartate (NMDA… 
2001
2001
Beaufour-Ipsen is developing gacyclidine (GK-11) for the potential treatment of traumatic brain injury. Phase II clinical trials… 
Review
2001
Review
2001
Beaufour-Ipsen is developing gacyclidine (GK-11) for the potential treatment of traumatic brain injury. Phase II clinical trials… 
2001
2001
The pharmacokinetics of gacyclidine enantiomers, a noncompetitive N-methyl-D-aspartate (NMDA) antagonist, were studied in plasma… 
2001
2001
Gacyclidine is a non‐competitive NMDA receptor antagonist with potent neuroprotective properties. However, we have previously… 
2000
2000
Prevention of the immediate excitotoxic phase occurring in response to spinal cord injury (SCI) is a major issue to reduce the… 
1999
1999
A sensitive gas chromatographic-mass spectrometric (GC-MS) procedure is described for the selective determination of gacyclidine…